Free Trial

Roivant Sciences (ROIV) Short Interest Ratio & Short Volume

Roivant Sciences logo
$11.68 +0.07 (+0.56%)
As of 10:35 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Roivant Sciences Short Interest Data

Roivant Sciences (ROIV) has a short interest of 51.23 million shares, representing 11.68% of the float (the number of shares available for trading by the public). This marks a 13.59% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.5, indicating that it would take 8.5 days of the average trading volume of 5.46 million shares to cover all short positions.

Current Short Interest
51,230,000 shares
Previous Short Interest
45,100,000 shares
Change Vs. Previous Month
+13.59%
Dollar Volume Sold Short
$515.37 million
Short Interest Ratio
8.5 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
713,549,000 shares
Float Size
438,660,000 shares
Short Percent of Float
11.68%
Today's Trading Volume
620,042 shares
Average Trading Volume
5,464,133 shares
Today's Volume Vs. Average
11%
Short Selling Roivant Sciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Roivant Sciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ROIV Short Interest Over Time

ROIV Days to Cover Over Time

ROIV Percentage of Float Shorted Over Time

Roivant Sciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/202551,230,000 shares $515.37 million +13.6%11.7%8.5 $10.06
3/31/202545,100,000 shares $455.06 million -13.4%10.3%7.7 $10.09
3/15/202552,090,000 shares $555.28 million +12.9%11.9%9.8 $10.66
2/28/202546,140,000 shares $495.54 million +8.8%10.4%10 $10.74
2/15/202542,400,000 shares $447.74 million +0.5%9.6%9.2 $10.56
1/31/202542,200,000 shares $469.69 million -6.0%9.4%8.8 $11.13
1/15/202544,880,000 shares $496.82 million +3.2%10.0%9.6 $11.07
12/31/202443,500,000 shares $514.61 million -1.6%11.5%9.4 $11.83
12/15/202444,200,000 shares $523.33 million -7.6%11.8%8.7 $11.84
11/30/202447,810,000 shares $607.67 million +10.3%12.6%8 $12.71
11/15/202443,350,000 shares $485.52 million -6.9%11.5%6.9 $11.20
10/31/202446,570,000 shares $537.88 million -7.2%12.4%8 $11.55
10/15/202450,190,000 shares $596.26 million -2.0%13.3%8.5 $11.88
9/30/202451,220,000 shares $591.08 million +52.6%13.6%8.3 $11.54
9/15/202433,570,000 shares $400.83 million -12.2%9.0%5.5 $11.94
8/31/202438,220,000 shares $467.43 million -6.6%8.6%7.7 $12.23
8/15/202440,900,000 shares $462.58 million -1.7%9.2%8.2 $11.31
7/31/202441,600,000 shares $451.36 million +1.8%9.3%8.5 $10.85
7/15/202440,850,000 shares $469.78 million -8.7%8.4%8.4 $11.50
6/30/202444,760,000 shares $473.11 million +11.7%8.8%9.2 $10.57
6/15/202440,070,000 shares $428.35 million +8.3%7.9%5.9 $10.69
5/31/202437,000,000 shares $383.32 million -5.0%7.3%5.5 $10.36
5/15/202438,930,000 shares $447.70 million -14.6%7.0%6 $11.50
4/30/202445,580,000 shares $496.82 million +1.0%8.3%6.6 $10.90
4/15/202445,130,000 shares $489.21 million +45.9%8.2%6.2 $10.84
3/31/202430,930,000 shares $326.00 million -2.0%5.6%4.2 $10.54
3/15/202431,570,000 shares $320.12 million +14.0%6.6%5.9 $10.14
2/29/202427,690,000 shares $316.77 million -3.8%5.8%5.1 $11.44
2/15/202428,770,000 shares $329.42 million +11.9%6.0%5.3 $11.45
1/31/202425,710,000 shares $257.10 million -19.6%5.4%4.8 $10.00
1/15/202431,990,000 shares $353.81 million +2.9%5.8%5.4 $11.06
12/31/202331,080,000 shares $349.03 million +9.3%5.7%5.3 $11.23
12/15/202328,440,000 shares $317.39 million -6.6%5.2%4.1 $11.16
11/30/202330,440,000 shares $291.01 million +1.9%5.6%4.6 $9.56
11/15/202329,870,000 shares $270.92 million -10.1%5.5%4.6 $9.07
10/31/202333,230,000 shares $287.11 million -6.3%6.2%5.2 $8.64
10/15/202335,460,000 shares $357.44 million +10.9%6.7%6.3 $10.08
9/30/202331,990,000 shares $373.64 million +74.4%6.1%6 $11.68
9/15/202318,340,000 shares $207.06 million -13.5%3.6%3.7 $11.29
8/31/202321,190,000 shares $245.17 million +3.9%4.9%4.2 $11.57
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
8/15/202320,390,000 shares $223.68 million -3.4%4.7%4.1 $10.97
7/31/202321,100,000 shares $252.78 million +0.8%4.9%4.5 $11.98
7/15/202320,940,000 shares $244.37 million -9.0%4.8%4.5 $11.67
6/30/202323,000,000 shares $231.84 million +42.5%5.3%5.2 $10.08
6/15/202316,140,000 shares $160.11 million +14.0%3.9%4.2 $9.92
5/31/202314,160,000 shares $128.71 million -1.6%3.4%4.4 $9.09
5/15/202314,390,000 shares $131.67 million +2.6%3.5%4.8 $9.15
4/30/202314,020,000 shares $119.87 million -4.1%3.4%4.8 $8.55
4/15/202314,620,000 shares $103.95 million +5.3%3.6%5 $7.11
3/31/202313,880,000 shares $102.43 million +32.8%3.4%5.1 $7.38
3/15/202310,450,000 shares $89.77 million -1.7%2.6%3.7 $8.59
2/28/202310,630,000 shares $86.00 million -0.5%2.7%4.4 $8.09
2/15/202310,680,000 shares $95.05 million -16.8%2.8%4.4 $8.90
1/31/202312,830,000 shares $106.49 million -26.4%3.5%5.5 $8.30
1/15/202317,420,000 shares $171.94 million +6.2%4.8%7.9 $9.87
12/30/202216,400,000 shares $131.04 million +15.7%4.5%8.2 $7.99
12/15/202214,180,000 shares $102.66 million +12.5%3.9%8.4 $7.24
11/30/202212,610,000 shares $67.59 million +2.6%3.6%8.8 $5.36
11/15/202212,290,000 shares $68.09 million -0.2%3.5%10.4 $5.54
10/31/202212,310,000 shares $63.27 million +5.4%3.6%11 $5.14
10/15/202211,680,000 shares $53.49 million +3.6%3.4%13 $4.58
9/30/202211,270,000 shares $36.29 million +8.3%3.3%12.9 $3.22
9/15/202210,410,000 shares $36.44 million +4.5%3.1%11.9 $3.50
8/31/20229,960,000 shares $35.46 million +6.5%2.9%11 $3.56
8/15/20229,350,000 shares $39.74 million +9.2%2.8%8.9 $4.25
7/31/20228,560,000 shares $34.07 million +5.0%2.5%8.5 $3.98
7/15/20228,150,000 shares $34.80 million +24.8%2.4%8.6 $4.27
6/30/20226,530,000 shares $26.58 million +9.8%2.0%7.1 $4.07
6/15/20225,950,000 shares $23.98 million +65.3%1.8%7.4 $4.03
5/31/20223,600,000 shares $15.98 million +60.0%1.1%5.1 $4.44
5/15/20222,250,000 shares $7.79 million -1.3%0.7%4.6 $3.46
4/30/20222,280,000 shares $8.41 million -4.2%0.7%5.8 $3.69
4/15/20222,380,000 shares $9.64 million -18.2%0.7%5.9 $4.05
3/31/20222,910,000 shares $14.38 million +3.2%0.9%7.7 $4.94
3/15/20222,820,000 shares $14.64 million -4.4%0.9%6.9 $5.19
2/28/20222,950,000 shares $18.56 million +0.7%0.9%5.1 $6.29
2/15/20222,930,000 shares $21.15 million +7.3%0.9%4.2 $7.22
1/31/20222,730,000 shares $18.24 million +4.2%0.8%3.7 $6.68
1/15/20222,620,000 shares $20.83 million +12.5%0.8%3.4 $7.95
12/31/20212,330,000 shares $23.49 million No Change0.7%3 $10.08

ROIV Short Interest - Frequently Asked Questions

What is Roivant Sciences' current short interest?

Short interest is the volume of Roivant Sciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 51,230,000 shares of ROIV short. 11.68% of Roivant Sciences' shares are currently sold short. Learn More on Roivant Sciences' current short interest.

What is a good short interest ratio for Roivant Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ROIV shares currently have a short interest ratio of 8.0. Learn More on Roivant Sciences's short interest ratio.

Which institutional investors are shorting Roivant Sciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Roivant Sciences: Wolverine Trading LLC, Group One Trading LLC, Citadel Advisors LLC, Jane Street Group LLC, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, and Twin Tree Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Roivant Sciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.68% of Roivant Sciences' floating shares are currently sold short.

Is Roivant Sciences' short interest increasing or decreasing?

Roivant Sciences saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 51,230,000 shares, an increase of 13.6% from the previous total of 45,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Roivant Sciences' float size?

Roivant Sciences currently has issued a total of 713,549,000 shares. Some of Roivant Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Roivant Sciences currently has a public float of 438,660,000 shares.

How does Roivant Sciences' short interest compare to its competitors?

11.68% of Roivant Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Roivant Sciences: BioNTech SE (1.84%), Summit Therapeutics Inc. (29.08%), Teva Pharmaceutical Industries Limited (2.69%), Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S (0.33%), Dr. Reddy's Laboratories Limited (1.91%), Ascendis Pharma A/S (11.37%), Moderna, Inc. (16.48%), Viatris Inc. (3.96%), Qiagen (2.11%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Roivant Sciences stock?

Short selling ROIV is an investing strategy that aims to generate trading profit from Roivant Sciences as its price is falling. ROIV shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Roivant Sciences?

A short squeeze for Roivant Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ROIV, which in turn drives the price of the stock up even further.

How often is Roivant Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ROIV, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:ROIV) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners